To stage or not to stage?-A cost minimization analysis of sacral neuromodulation placement strategies.
Andrew J SunCatherine R HarrisCraig Vance ComiterChristopher S ElliottPublished in: Neurourology and urodynamics (2019)
Using Medicare reimbursement, single-stage SNM placement is likely to be less costly than 2-stage placement for most practitioners. The savings are tied to SNM success rates and reimbursement rates, with reduced costs up to $5014 per case in centers of excellence (≥ 90% success).
Keyphrases